Subsequently, a Mexican study examined both cervical cancer tissue sections (n = 44, GPER immunohistochemistry) and cervical cancer cell lines (the effect of GPER agonist G1 on SiHa, HeLa, and C-33A) [250]. Here, GPER1 is linked to cervical cancer.